How to Formally Present
a Review of a Study
Teresa O'Sullivan, Pharm.D., BCPS
Director, Professional Experience Programs
School of Pharmacy
University of Washington
Seattle, Washington 98195-7631
(206) 543-3324
Email: terrio@u.washington.edu
You should be able to outline and evaluate a
publication in 10 minutes or less. Strive to paraphrase,
rather than quote.
Study Outline
- Introduction
- Title
- Authors
- Name of lead author; can include
any other author who is significant
- Number of other
authors
- Qualifications of authors: where
are they from (general, e.g., McGill University, OHSU,
Harvard); training of authors (e.g., 2 pediatricians and 1
PhD, probably statistician)
- Funding.
Drug company versus government agency versus foundation,
etc.
- Study
Objective. A single sentence
description of what study tried examine or answer.
- Background.
A description of problem leading to study and previous work or
lack of work which led to study. Some of this will be in the
introduction, but you will also, illogically, find much of this
information in the methods and discussion sections as
well.
- Methods
- Design.
This should be a short descriptive phrase describing study
design.
- Setting.
Note where, geographically, the study took place (e.g.
Netherlands, Northeast USA, 37 countries around the
world).
- Sample
population. A description of
the entire group of patients available to the investigators
from which to choose the sample. Hopefully this population will
be the same for both groups.
- Inclusion
criteria. Paraphrase as much
as possible.
- Exclusion
criteria. Omit if information
basically covered in inclusion criteria.
- Intervention.
Include information about how sample members were allocated to
treatment, what that treatment was, how outcome measures were
tested for, and describe the follow-up process.
- Major study
endpoints. What are the
primary and secondary outcome measures?
- Statistical
analysis. Describe what tests
were done, and state whether or not each was appropriate and
why. Also explain why other tests may have been more
appropriate.
- Results
- Patients
- How many patients were in each
group?
- How did their baseline
characteristics compare?
- Endpoints
- Primary endpoints
- Secondary endpoints
- Note any other outcomes that were
particularly interesting
- Include raw numbers as well as
information about statistical significance
- Discussion
- Conclusion
of study authors in one sentence.
- Discussion
information presented by authors
Presenter's Evaluation
- Study
strengths. List and
justify.
- Study
weaknesses. List and
justify--study strengths and weaknesses must consider potential
bias, confounding, and significance
- Applicability.
Present overall opinion of study and state how study could fit
into the practice of pharmacy.
| External
PharmD Home Page |
Stanley S. Weber, Pharm.D,
FASHP, BCPP
Director, Joint Doctor of
Pharmacy Degree Program
University of Washington
and Washington State University
Copyright ©
1997-9
Comments: expharmd@u.washington.edu
Revised: June 9, 1999